
About Silhos Pharma Limited
Data last updated:
Silhos Pharma Limited is a public limited company based in Shahabad Markanda, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304HR2017PLC067875. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Gourav and Parul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.8 New Vishwas Complex, Shahabad Markanda, Haryana, India – 136135.
As per the financials filed for FY 2023, the company reported a revenue of ₹54.53 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net loss of ₹15,444 (net margin -0.3%) and EBITDA of ₹18,233 (EBITDA margin 0.3%). Revenue has declined at a compounded annual rate (CAGR) of 81% over three years and 30% over five years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website silhospharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH.No.8 New Vishwas Complex, Shahabad Markanda, Haryana, India – 136135
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Silhos Pharma Limited FY 2025 filings available
Silhos Pharma Limited reported revenue of ₹54.53 Lakh (down 28% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Silhos Pharma Limited
Revenue has declined at a compounded annual rate (CAGR) of 30% over five years, including a 28% fall in the latest year. EBITDA fell 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Silhos Pharma Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹54.53 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹18,233 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹15,444 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Silhos Pharma Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Silhos Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Silhos Pharma Limited
Silhos Pharma Limited is audited by Anuj Bansal & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Anuj Bansal & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Silhos Pharma Limited
Silhos Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gourav Also directs: Pidolma Healthcare Private Limited | Director | 17 Jan 2022 | 4 Years 8 Months | Current |
| Parul | Director | 17 Jan 2022 | 4 Years 8 Months | Current |
| Om Parkash Also directs: Pidolma Healthcare Private Limited | Director | 17 Jan 2022 | 4 Years 8 Months | Current |
Ownership and Shareholding of Silhos Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Silhos Pharma Limited
Silhos Pharma Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Silhos Pharma Limited
Silhos Pharma Limited has 1 court case on record: 1 filed against it. All case is pending. Status as checked on 29 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nagpur, Maharashtra | Court case (R.C.C.) | Filed against the company by State of Maharashtra | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Silhos Pharma Limited
Employment history and EPFO contributions of people linked to Silhos Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Silhos Pharma Limited
Silhos Pharma Limited has 12 board changes on record since 2017: 8 appointments and 4 cessations. The latest: Himanshu ceased to be Director on 25 Jan 2022.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Silhos Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Silhos Pharma Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Silhos Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Silhos Pharma Limited
Silhos Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Silhos Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Silhos Pharma Limited
Silhos Pharma is an active public limited company based in Shahabad Markanda, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 February 2017 (9+ years old) and is registered under CIN U24304HR2017PLC067875.
Silhos Pharma reported revenue of ₹54.53 Lakh for FY 2023 (down 28% YoY).
Silhos Pharma has 3 current directors:
- Gourav - Director
- Parul - Director
- Om Parkash - Director
Silhos Pharma reported a net loss of ₹15,444 (net margin -0.3%) and EBITDA of ₹18,233 (EBITDA margin 0.3%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Silhos Pharma is 81% over three years and -30% over five years. In the latest year (FY 2023) revenue fell 28%. CAGR is the steady yearly rate that links the first and the last year.
No. Silhos Pharma has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Silhos Pharma is U24304HR2017PLC067875. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Silhos Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Silhos Pharma was incorporated on 27 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Himanshu ceased to be Director on 25 Jan 2022. Kashish Dawra ceased to be Director on 25 Jan 2022. Ruchir Kumar ceased to be Director on 25 Jan 2022. Silhos Pharma has 12 board changes on record in total.